Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Recipient Signaling through the Cannabinoid Type 2 Receptor Regulates IL-6 Independent Neuroinflammation during Graft Versus Host Disease

Alison Moe, PhD, Garrett Sauber, BS, Vivian Zhou, PhD, Anissa Lapitz, BS, Cecilia Hillard, PhD, William R. Drobyski, MD

Blood (2019) 134 (Supplement_1): 195.

https://doi.org/10.1182/blood-2019-122746

Published: 2019

Journal Articles

Single Cell Immune Profiling of Colitogenic T Cells during Acute Graft Versus Host Disease Reveals Two Novel Transcriptionally Distinct CD4+ GM-CSF+ Lineages

Clinton Piper, BS, Achia Khatun, BS, Yao Chen, BS, Ryan Zander, PhD, Weiguo Cui, MD PhD, William R. Drobyski, MD

Blood (2019) 134 (Supplement_1): 197.

https://doi.org/10.1182/blood-2019-127095

Published: 2019

Journal Articles

A Bhlhe40/GM-CSF Axis Potentiates Gastrointestinal Tract Inflammation during Acute Graft Versus Host Disease

Clint Piper, BS, Vivan Zhou, PhD, Brian T. Edelson, MD PhD, Reshma Taneja, William R. Drobyski, MD

Blood (2018) 132 (Supplement 1): 62.

https://doi.org/10.1182/blood-2018-99-110807

Published: 2018

Journal Articles

Bim Regulates the Survival and Suppressive Capability of CD8+ Foxp3+ Regulatory T Cells during Graft Versus Host Disease

Benjamin G. Vincent, MD, Kimberle A. Agle, PhD, Ludovic Belle, PhD, Vivan Zhou, PhD, Clint Piper, BS, Warren D Shlomchik, MD, Jonathan S Serody, MD, William R. Drobyski, MD

Blood (2017) 130 (Supplement 1): 209.

https://doi.org/10.1182/blood.V130.Suppl_1.209.209

Published: 2017

Journal Articles

Ixazomib for Chronic Graft-Versus-Host Disease (cGVHD) Prophylaxis in Patients Undergoing Allogeneic Transplantation (alloHCT): Preliminary Results of a Phase I/II Study

Saurabh Chhabra, MD, Parameswaran Hari, MD MRCP, MS, Alexis Visotcky, Nirav N Shah, MD, J. Douglas Rizzo, MD, Wael Saber, MD MS, Anita D'Souza, MBBS, Binod Dhakal, MBBS, Ashish Anshu, MS, PhD, Robert Thompson, Timothy S. Fenske, MD, Bronwen E. Shaw, PhD MRCP, FRCPath, William R. Drobyski, MD, Marcelo C. Pasquini, MD, Mehdi Hamadani, MD

Blood (2017) 130 (Supplement 1): 1974.

https://doi.org/10.1182/blood.V130.Suppl_1.1974.1974

Published: 2017

Journal Articles

Impact of Obesity on Outcomes of Elderly Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Myeloid Malignancies

Ensi Voshtina, DO, Aniko Szabo, PhD, Mehdi Hamadani, MD, Tim S. Fenske, MD, Anita D'Souza, MBBS, MD, Wael Saber, MD MS, William R. Drobyski, MD, Parameswaran Hari, MBBS, MD MRCP, Nirav N. Shah, MD MSHP

Blood (2016) 128 (22): 4667.

https://doi.org/10.1182/blood.V128.22.4667.4667

Published: 2016

Journal Articles

Host Interleukin 6 and Indoleamine 2,3 Dioxygenase Regulate Inflammation in the Brain during Graft Versus Host Disease

Ludovic Belle, PhD, Erin Koester, MS, Emily Hansen, PhD, Michael Lawlor, PhD, Cecilia Hillard, PhD, William R. Drobyski, MD

Blood (2016) 128 (22): 2145.

https://doi.org/10.1182/blood.V128.22.2145.2145

Published: 2016

Journal Articles

Tocilizumab Is Highly Active for Severe Steroid-Refractory Acute Graft-Versus-Host Disease of the Gastrointestinal Tract

Alex Ganetsky, PharmD, BCOP, Noelle V Frey, MD, Alison W Loren, MD MS, Elizabeth O. Hexner, MD, James K Mangan, MD PhD, Saar I Gill, MBBS, PhD, Selina Luger, MD, Adam D. Cohen, MD, Daria V Babushok, MDPhD, Edward A Stadtmauer, MD, Jacqueline Smith, CRNP, William R. Drobyski, MD, Sarah K Kraus, PharmD, Colleen Timlin, PharmD, BCOP, David L. Porter, MD

Blood (2016) 128 (22): 2245.

https://doi.org/10.1182/blood.V128.22.2245.2245

Published: 2016

Journal Articles

Blockade of Interleukin 27 Signaling Attenuates Graft Versus Host Disease By Augmenting CD4 + and CD8 + Regulatory T Cell Reconstitution

Ludovic Belle, PhD, Kimberle A. Agle, PhD, Vivian Zhou, PhD, Vanessa Yuan, MS, Jie Sun, PhD, Nico Ghilardi, PhD, Jacques van Snick, PhD, William R. Drobyski, MD

Blood (2015) 126 (23): 150.

https://doi.org/10.1182/blood.V126.23.150.150

Published: 2015

Journal Articles

Coordinate Expression of Beta 2 Integrins and the Interleukin 23 Receptor Define a Pathogenic CD4+ T Cell Population That Induces Colonic Inflammation during Graft Versus Host Disease

Kimberle Agle, PhD, Vivian Zhou, PhD, Xiao Chen, MD PhD, Amy Beres, PhD, Richard Komorowski, MD, Carolyn Taylor, PhD, Dipica Haribhai, Calvin Williams, MD PhD, James Verbsky, MDPhD, Wendy Blumenschein, PhD, Svetlana Sadekova, PhD, Eddie Bowman, PhD, Casey Weaver, MD, Daniel Cua, PhD, William R. Drobyski, MD

Blood (2014) 124 (21): 537.

https://doi.org/10.1182/blood.V124.21.537.537

Published: 2014

Journal Articles

A Critical Role for the Retinoic Acid Signaling Pathway in the Pathophysiology of Gastrointestinal Graft-Versus-Host Disease

Xiao Chen, MD, PhD, Joseph Dodge, William R. Drobyski, MD

Blood (2012) 120 (21): 341.

https://doi.org/10.1182/blood.V120.21.341.341

Published: 2012

Journal Articles

Emergence of Donor T Cells That Recognize Nonpolymorphic Antigens During Graft Versus Host Disease,

Hemalatha Rangarajan, MD, Maryam Yassai, Xiao Chen, MD, PhD, Richard Komorowski, MD, Jack Gorski, PhD, William R. Drobyski, MD

Blood (2011) 118 (21): 4013.

https://doi.org/10.1182/blood.V118.21.4013.4013

Published: 2011

Journal Articles

HLA DR15 Antigen Status Does Not Impact Graft-Versus-Host Disease or Disease-Free Survival in HLA-Matched Sibling Transplantation for Hematologic Malignancies

Blood (2011) 118 (21): 3094.

https://doi.org/10.1182/blood.V118.21.3094.3094

Published: 2011

Journal Articles

Induction of a Novel Population of CD8 + Foxp3 + Regulatory T Cells During Graft Versus Host Disease

Amy Beres, BS, Dipica Haribhai, Chelsea Tessler-Verville, BS, Patrick Gonyo, BS, Martin Hessner, PhD, Calvin Williams, MD, PhD, William R. Drobyski, MD

Blood (2011) 118 (21): 821.

https://doi.org/10.1182/blood.V118.21.821.821

Published: 2011

Journal Articles

Stability of Foxp3 Expression Is a Critical Factor In the Ability of Regulatory T Cells to Mitigate Graft Versus Host Disease

Amy Beres, Richard Komorowski, MD, William R. Drobyski, MD

Blood (2010) 116 (21): 731.

https://doi.org/10.1182/blood.V116.21.731.731

Published: 2010

Journal Articles

Blockade of IL-23 Signaling Results in Targeted Protection of the Colon and Allows for Separation of Graft Versus Host and Graft Versus Leukemia Effects.

Rupali Das, Ph.D., Richard Komorowski, M.D., Martin Hessner, Ph.D., Hariharan Subramaniam, PhD, Daniel J Cua, PhD, Claudia Huettner, PhD, William R. Drobyski, MD

Blood (2009) 114 (22): 231.

https://doi.org/10.1182/blood.V114.22.231.231

Published: 2009

Journal Articles

Interleukin 23 Secretion by Donor Antigen Presenting Cells Is Critical for Organ-Specific Pathology in Graft Versus Host Disease

Rupali Das, Ph.D., Xiao Chen, Ph.D., Richard Komorowski, M.D., Martin Hessner, Ph.D., William R. Drobyski, MD

Blood (2008) 112 (11): 64.

https://doi.org/10.1182/blood.V112.11.64.64

Published: 2008

Journal Articles

Inhibition of Interleukin 17 Significantly Attenuates the Severity of Autoimmune-Mediated Pathological Damage in Chronic Graft Versus Host Disease.

Xiao Chen, MD, PhD, Jacques Van Snick, Catherine Uyttenhove, Richard Komorowski, MD, William R. Drobyski, MD

Blood (2007) 110 (11): 70.

https://doi.org/10.1182/blood.V110.11.70.70

Published: 2007

Journal Articles

Inhibition of T Cell Alloreactivity by Gr-1 + Mac-1 + Myeloid Suppressor Cells.

Xiao Chen, MD, PhD, Jon Anderson, William R. Drobyski, MD

Blood (2006) 108 (11): 5177.

https://doi.org/10.1182/blood.V108.11.5177.5177

Published: 2006

Journal Articles

Homeostatic Expansion and Repertoire Regeneration of Donor T Cells during Graft Versus Host Disease Is Constrained by the Host Environment.

Xiao R. Chen, MD, PhD, Maria Gendelman, Maryam Yassai, Elizabeth Tivol, PhD, Sanja Vodanovic-Jankovic, MD, PhD, Jack Gorski, PhD, William R. Drobyski, MD

Blood (2006) 108 (11): 342.

https://doi.org/10.1182/blood.V108.11.342.342

Published: 2006

NARROW

Recipient Signaling through the Cannabinoid Type 2 Receptor Regulates IL-6 Independent Neuroinflammation during Graft Versus Host Disease

Single Cell Immune Profiling of Colitogenic T Cells during Acute Graft Versus Host Disease Reveals Two Novel Transcriptionally Distinct CD4+ GM-CSF+ Lineages

A Bhlhe40/GM-CSF Axis Potentiates Gastrointestinal Tract Inflammation during Acute Graft Versus Host Disease

Bim Regulates the Survival and Suppressive Capability of CD8+ Foxp3+ Regulatory T Cells during Graft Versus Host Disease

Ixazomib for Chronic Graft-Versus-Host Disease (cGVHD) Prophylaxis in Patients Undergoing Allogeneic Transplantation (alloHCT): Preliminary Results of a Phase I/II Study

Impact of Obesity on Outcomes of Elderly Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Myeloid Malignancies

Host Interleukin 6 and Indoleamine 2,3 Dioxygenase Regulate Inflammation in the Brain during Graft Versus Host Disease

Tocilizumab Is Highly Active for Severe Steroid-Refractory Acute Graft-Versus-Host Disease of the Gastrointestinal Tract

Blockade of Interleukin 27 Signaling Attenuates Graft Versus Host Disease By Augmenting CD4 + and CD8 + Regulatory T Cell Reconstitution

Coordinate Expression of Beta 2 Integrins and the Interleukin 23 Receptor Define a Pathogenic CD4+ T Cell Population That Induces Colonic Inflammation during Graft Versus Host Disease

A Critical Role for the Retinoic Acid Signaling Pathway in the Pathophysiology of Gastrointestinal Graft-Versus-Host Disease

Emergence of Donor T Cells That Recognize Nonpolymorphic Antigens During Graft Versus Host Disease,

HLA DR15 Antigen Status Does Not Impact Graft-Versus-Host Disease or Disease-Free Survival in HLA-Matched Sibling Transplantation for Hematologic Malignancies

Induction of a Novel Population of CD8 + Foxp3 + Regulatory T Cells During Graft Versus Host Disease

Stability of Foxp3 Expression Is a Critical Factor In the Ability of Regulatory T Cells to Mitigate Graft Versus Host Disease

Blockade of IL-23 Signaling Results in Targeted Protection of the Colon and Allows for Separation of Graft Versus Host and Graft Versus Leukemia Effects.

Interleukin 23 Secretion by Donor Antigen Presenting Cells Is Critical for Organ-Specific Pathology in Graft Versus Host Disease

Inhibition of Interleukin 17 Significantly Attenuates the Severity of Autoimmune-Mediated Pathological Damage in Chronic Graft Versus Host Disease.

Inhibition of T Cell Alloreactivity by Gr-1 + Mac-1 + Myeloid Suppressor Cells.

Homeostatic Expansion and Repertoire Regeneration of Donor T Cells during Graft Versus Host Disease Is Constrained by the Host Environment.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only